文献速递眼整形与眼眶神经眼科

甲状腺眼病及其威胁视力的表现在美国眼科学会IRIS登记系统中的研究:2014-2018年

Thyroid Eye Disease and its Vision-Threatening Manifestations in the Academy IRIS Registry: 2014-2018.
PubMed 文献 · Am J Ophthalmol · 2023-05-17

该研究为美国眼科学会IRIS登记系统的横断面分析,纳入18-90岁患者,识别出41,211例甲状腺眼病(TED)患者,患病率为0.09%,呈单峰年龄分布(50-59岁最高,0.12%),女性高于男性(0.12% vs 0.04%),非西班牙裔高于西班牙裔(0.10% vs 0.05%),不同种族患病率存在差异(亚裔0.08%至黑人/非裔美国人0.12%)。多变量分析显示年龄、女性、吸烟和1型糖尿病与TED相关。

要点

  • TED总体患病率为0.09%,50-59岁年龄组患病率最高(0.12%)。
  • 女性患病率0.12%高于男性0.04%,非西班牙裔0.10%高于西班牙裔0.05%。
  • 吸烟(当前吸烟OR 2.16)和1型糖尿病(OR 1.87)与TED相关。

核心结论

  • TED的流行病学特征包括单峰年龄分布和种族患病率差异等新发现。
  • 女性、吸烟和1型糖尿病的关联与既往报告一致。
  • 这些发现提出了关于不同人群中TED的新问题。

研究设计与样本

  • 美国眼科学会IRIS登记系统的横断面分析。
  • 纳入18-90岁患者,根据ICD-9(242.00)或ICD-10(E05.00)在至少2次就诊中编码为TED者归类为TED,其余为非TED。
  • 共识别41,211例TED患者,使用逻辑回归估计比值比(OR)和95%置信区间(CI)。

主要发现

  • TED患病率为0.09%,年龄分布呈单峰,50-59岁患病率最高(0.12%)。
  • 女性患病率0.12% vs 男性0.04%;非西班牙裔0.10% vs 西班牙裔0.05%。
  • 种族患病率从亚裔0.08%至黑人/非裔美国人0.12%,且患病率峰值年龄不同。
  • 多变量分析中,年龄30-39岁OR 2.2(95%CI 2.0,2.4)、40-49岁OR 2.9(2.7,3.1)、50-59岁OR 3.3(3.1,3.5)、60-69岁OR 2.7(2.54,2.85)、70岁及以上OR 1.5(1.46,1.64),均以18-<30岁为参照。
  • 女性 vs 男性OR 3.5(3.4,3.6);黑人 vs 白人OR 1.1(1.1,1.2);亚裔 vs 白人OR 0.9(0.8,0.9);西班牙裔 vs 非西班牙裔OR 0.68(0.6,0.7);既往吸烟 vs 从不吸烟OR 1.64(1.6,1.7);当前吸烟 vs 从不吸烟OR 2.16(2.1,2.2);1型糖尿病 vs 无OR 1.87(1.8,1.9)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate prevalence of thyroid eye disease (TED) and associated factors in the American Academy of Ophthalmology IRISⓇ Registry (Intelligent Research in Sight). DESIGN: Cross-sectional analysis of the IRIS Registry. METHODS: IRIS Registry patients (18-90 years old) were classified as TED (ICD-9: 242.00, ICD-10: E05.00 on ≥2 visits) or non-TED cases, and prevalence was estimated. Odds ratios (OR) and 95% Confidence Intervals (CIs) were estimated using logistic regression. RESULTS: 41,211 TED patients were identified. TED prevalence was 0.09%, showed a unimodal age distribution (highest prevalence in ages 50-59 years (y) (0.12%)), higher rates in females than males (0.12% vs. 0.04%) and in non-Hispanics than Hispanics (0.10% vs. 0.05%). Prevalence differed by race (from 0.08% in Asians to 0.12% in Black/African-Americans), with varying peak ages of prevalence. Factors associated with TED in multivariate analysis included age: ((18-<30y (reference), 30-39y: OR (95%CI) 2.2 (2.0, 2.4), 40-49y: 2.9 (2.7,3.1), 50-59y: 3.3 (3.1, 3. 5), 60-69y: 2.7 (2.54, 2.85), 70+: 1.5 (1.46, 1.64)); female sex vs male (reference), 3.5 (3.4,3.6), race: White (reference), Blacks: 1.1 (1.1,1.2), Asian: 0.9 (0.8,0.9), Hispanic ethnicity vs not Hispanic (reference), 0.68 (0.6,0.7), smoking status: (never (ref), former: 1.64 (1.6,1.7), current 2.16: (2.1,2.2)) and Type 1 diabetes (yes vs no (reference): 1.87 (1.8, 1.9). CONCLUSIONS: This epidemiologic profile of TED includes new observations such as a unimodal age distribution and racial variation in prevalence. Associations with female sex, smoking, and Type 1 diabetes are consistent with prior reports. These findings raise novel questions about TED in different populations.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Ramesh S, Zhang QE, Sharpe J, et al. Thyroid Eye Disease and its Vision-Threatening Manifestations in the Academy IRIS Registry: 2014-2018. Am J Ophthalmol. 2023. PMID: 37201696. doi:10.1016/j.ajo.2023.04.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。